---
format:
  revealjs:
    html: true
    css: index.css
    footer: "Jacob Widaeus - Karolinska Institute, Department of Clinical Sciences, Danderyd Hospital"
    incremental: false
---
# Individual study plan
**Bedside assessment of Microvascular Dysfunction**
<br>
Method evaluation in clinical studies
<div style="margin-top: 120px;"></div>
<span style="font-size:20px;">**Supervisor**: Sara Tehrani, MD, PhD, MICU specialist</span>
<br>
<span style="font-size:20px;">**Co-Supervisor**: Maria Cronhjort, MD, PhD, anesthesiologist and ICU specialist</span>
<br>
<img src="images/ki-ds.png" class="logo">
---

#### Disposition
- <span style="font-size:30px;">**Introduction and Background**: Introduction to the topic, research objectives</span>
- <span style="font-size:30px;">**Research plan and Methodology**: Study designs, methods and analysis</span>
- <span style="font-size:30px;">**Education**: Courses, journal clubs, conferences</span>
- <span style="font-size:30px;">**Timeline and Milestones**: Project timeline with key milestones</span>
- <span style="font-size:30px;">**Degree outcomes**</span>
- <span style="font-size:30px;">**Resources and Support**: Overview of resources and support</span>
<div style="text-align: center;">
  <img src="images/qrcode.png" style="width: 200px;">
</div>
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Introduction and Background</span>

#### Relevance
<img src="images/vascular-man.jpg" style="width:35%; display: block; margin: auto;">
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Introduction and Background</span>

#### Relevance
<img src="images/vascular-man.jpg" style="width:17%; position: absolute; top: 1px; right: 1px;">
<span style="font-size:25px;">**Key Areas**: Cardiovascular disease, diabetes, heart failure, sepsis</span>

<span class="fragment" data-fragment-index="1" style="font-size:25px;">Clinical Implications</span>

<span class="fragment" data-fragment-index="2" style="font-size:20px;">**Early Detection and Prevention**: Monitoring microvascular function helps identify patients at high risk, enabling early intervention and preventive measures.</span>

<span class="fragment" data-fragment-index="3" style="font-size:20px;">**Disease Progression and Treatment Monitoring**: Microvascular assessment provides a window into disease activity, aiding in the evaluation of treatment effectiveness.</span>

<span class="fragment" data-fragment-index="4" style="font-size:20px;">**Goal-Directed Therapy**: Insights into microvascular health support goal-directed therapies, optimizing treatment plans tailored to individual needs.</span>
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Introduction and Background</span>

#### Problem
<div style="margin-bottom: 30px;"></div>

<span style="font-size:25px;">**Current methods**</span>

:::: {.columns}

::: {.column width="35%"}
<div class="fragment" data-fragment-index="1" style="font-size:25px; margin-bottom: 40px;">Capillary refill time</div>
<div class="fragment" data-fragment-index="1" style="font-size:25px; margin-bottom: 40px;">Stress Cardiac MRT</div>
<div class="fragment" data-fragment-index="1" style="font-size:25px; margin-bottom: 40px;">Coronary angiography</div>
<div class="fragment" data-fragment-index="1" style="font-size:25px; margin-bottom: 40px;">Biomarkers</div>
:::

::: {.column width="65%"}
<div class="fragment" data-fragment-index="2" style="font-size:25px; padding-left: 20px; margin-bottom: 40px;">Subjectivity, variability, sens/spec, non-quantifiable</div>
<div class="fragment" data-fragment-index="2" style="font-size:25px; padding-left: 20px; margin-bottom: 40px;">Cumbersome, resource intensive, organ specific</div>
<div class="fragment" data-fragment-index="2" style="font-size:25px; padding-left: 20px; margin-bottom: 40px;">Invasive, cumbersome, resource intensive, organ specific</div>
<div class="fragment" data-fragment-index="2" style="font-size:25px; padding-left: 20px; margin-bottom: 40px;">Analysis time, interpretation, resource intensive</div>
:::

::::
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Introduction and Background</span>

#### Problem
<div style="margin-bottom: 30px;"></div>

<span style="font-size:25px;">**Future methods - what is needed?**</span>

:::: {.columns}

::: {.column width="40%"}
<div class="fragment" data-fragment-index="1" style="font-size:25px; margin-bottom: 35px;">Quantitative</div>
<div class="fragment" data-fragment-index="1" style="font-size:25px; margin-bottom: 35px;">Non-invasive</div>
<div class="fragment" data-fragment-index="1" style="font-size:25px; margin-bottom: 35px;">Low variability and High sensitivity</div>
<div class="fragment" data-fragment-index="1" style="font-size:25px; margin-bottom: 35px;">Rapid and ease of use</div>
<div class="fragment" data-fragment-index="1" style="font-size:25px; margin-bottom: 35px;">Organ-agnostic</div>
<div class="fragment" data-fragment-index="1" style="font-size:25px; margin-bottom: 35px;">Cost-effective</div>
:::

::: {.column width="60%"}
<div class="fragment" data-fragment-index="2" style="font-size:25px; padding-left: 20px; margin-bottom: 35px;">Precision and comparison</div>
<div class="fragment" data-fragment-index="2" style="font-size:25px; padding-left: 20px; margin-bottom: 35px;">Risk and discomfort</div>
<div class="fragment" data-fragment-index="2" style="font-size:25px; padding-left: 20px; margin-bottom: 35px;">Consistency and precision</div>
<div class="fragment" data-fragment-index="2" style="font-size:25px; padding-left: 20px; margin-bottom: 35px;">Clinical convenience</div>
<div class="fragment" data-fragment-index="2" style="font-size:25px; padding-left: 20px; margin-bottom: 35px;">Systemic dysfunction</div>
<div class="fragment" data-fragment-index="2" style="font-size:25px; padding-left: 20px; margin-bottom: 35px;">Iterative usage and goal-directed</div>
:::

::::

<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Research Plan and Methodology</span>
<br>
Picture of LSCI
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Research Plan and Methodology</span>
<br>
Picture of curves
<br>
<img src="images/ki-ds.png" class="logo">
---

#### Research Plan and Methodology

- <span style="font-size:30px;">**The CapriS Study, Capillary Dysfunction in Sepsis**</span>
  - <span style="font-size:25px;">Patients with severe sepsis or septic shock</span>
  - <span style="font-size:20px;">Rapid microvascular decompensation</span>

- <span style="font-size:30px;">**The MIND Study, Microangiopathy in Diabetes**</span>
  - <span style="font-size:25px;">Patients with type 1 diabetes, with and without clinical microangiopathy</span>
  - <span style="font-size:20px;">Chronic microvascular deterioration</span>

- <span style="font-size:30px;">**SCAPIS2Spectrum, Microcirculation Substudy**</span>
  - <span style="font-size:25px;">Patients with high risk of cardiac microangiopathy</span>
  - <span style="font-size:20px;">Microangiopathy in different populations</span>
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Research Plan and Methodology</span>

#### CapriS, Capillary Dysfunction in Sepsis
<span style="font-size: 19px;">**Population:** 60 patients, &gt;18 yrs with confirmed/suspected infection at ICU/IMCU &lt;12hrs and SBP &lt;90mmHg despite 10 mL/kg cristalloid.</span>
<div style="margin-bottom: 1px;"></div>
<span style="font-size: 19px;">**Intevention:** Laser speckle contrast imaging, with iontophoresis. Biomarkers. Echocardiography at set intervals.</span>
<div style="text-align: center;">
  <img src="images/capris_studyprotocol.png" style="width: 60%;">
</div>
<span style="font-size: 19px;">**Comparison:** 30 healthy controls.</span>
<div style="margin-bottom: 1px;"></div>
<span style="font-size: 19px;">**Outcomes:** *Primary outcome:* peak capillary blood cell velocity (pCVB, mm/s). *Secondary outcomes:* Severity of condition, macrocirculatory parameters, biomarkers.</span>
---

<span style="font-size: 20px;">Research Plan and Methodology</span>

#### MIND, Microangiopathy in Diabetes
<span style="font-size: 20px;">**Population:** Patients with DM1 at diabetes outpatient clinic at Danderyd Hospital.</span>
<br>
<span style="font-size: 20px;">*Pilot:* 20 healthy controls.</span>
<br>
<span style="font-size: 20px;">*Phase 1:* 50 patients with severe DM1 complications and 50 healthy controls.</span>
<br>
<span style="font-size: 20px;">*Phase 2:* 100 patients with no microangiopathy, 100 patients with mild microangiopathy, 50 with moderate microangiopathy, as classified by microangiopathy score <a href="https://journals.sagepub.com/doi/full/10.1177/1479164120928303">[1]</a>.</span>
<br>
<span style="font-size: 20px;">**Intervention:** LSCI, blood tests and charts.</span>
<br>
<span style="font-size: 20px;">**Controls:** Healthy controls in each cohort.</span>
<br>
<span style="font-size: 20px;">**Outcomes:** Thermal regulation, flow regulation</span>
<br>
  <img src="images/ki-ds.png" class="logo">
<br>
<span style="font-size: 20px;">[1]: <a href="https://doi.org/10.1177/1479164120928303">10.1177/1479164120928303</a></span>
---

<span style="font-size: 20px;">Research Plan and Methodology</span>

#### SCAPIS2Spectrum, Microcirculation Substudy
<span style="font-size: 20px;">**Population:** Substudy to SCAPIS2. 900 in total to be included in 5 arms; O-CAD, ANOCA, HFpEF, HFrEF and diabetes, including corresponding healthy controls from SCAPIS2 cohort.</span>
<br>
<br>
<span style="font-size: 20px;">**Intervention:** LSCI, biomarkers, and adenosine stress cardiac MRI.</span>
<br>
<br>
<span style="font-size: 20px;">**Comparison:** Healthy controls</span>
<br>
<br>
<span style="font-size: 20px;">**Outcome:** *Primary outcomes:* Flowmotion analysis, post-occlusion hyperemeia, thermal provocations. *Secondary outcomes:* Biomarkers</span>
<br>
<img src="images/ki-ds.png" class="logo">
---

<div style="text-align: center;">
  <img src="images/scapis2_inclusion.png" style="width: 56%;">
</div>
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Education</span>

#### Mandatory courses
:::: {.columns}
::: {.column width="50%"}
<br>
<span style="font-size:20px;"><br>Introduction to Doctoral Education at KI</span>
<span style="font-size:20px;"><br>Basic Laboratory Safety</span>
<span style="font-size:20px;"><br>Medical Research Ethics</span>
<span style="font-size:20px;"><br>Basic Course in Medical Statistics</span>
<span style="font-size:20px;"><br>Present your Research!</span>
<span style="font-size:20px;"><br>Quality Assurance of Clinical Research</span>
:::

::: {.column width="20%"}
<span style="font-size:20px;"><br>Completion date</span>
<span style="font-size:20px;"><br>2024-12</span>
<span style="font-size:20px;"><br>2025-01</span>
<span style="font-size:20px;"><br>2025-02</span>
<span style="font-size:20px;"><br>2025-03</span>
<span style="font-size:20px;"><br>2025-11</span>
<span style="font-size:20px;"><br>2025-11</span>
<span style="font-size:20px;"><br>**sum**</span>
:::

::: {.column width="10%"}
<br>
<span style="font-size:20px;"><br>1 hp</span>
<span style="font-size:20px;"><br>1,8 hp</span>
<span style="font-size:20px;"><br>1,5 hp</span>
<span style="font-size:20px;"><br>3 hp</span>
<span style="font-size:20px;"><br>1,5 hp</span>
<span style="font-size:20px;"><br>1,5 hp</span>
<span style="font-size:20px;"><br>**10,3 hp**</span>
:::

:::: 
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Education</span>

#### Project specific courses
:::: {.columns}
::: {.column width="50%"}
<br>
<span style="font-size:20px;"><br>Programming in Python</span>
<span style="font-size:20px;"><br>Statistical Methods with R</span>
<span style="font-size:20px;"><br>Introductory Course in Clinical Studies</span>
<span style="font-size:20px;"><br>Endothelial Cell Function</span>
<span style="font-size:20px;"><br>Intermediate Medical Statistics</span>
<span style="font-size:20px;"><br>Cellular Signaling</span>
:::

::: {.column width="20%"}
<span style="font-size:20px;"><br>Completion date</span>
<span style="font-size:20px;"><br>2024-10</span>
<span style="font-size:20px;"><br>2024-11</span>
<span style="font-size:20px;"><br>2025-02</span>
<span style="font-size:20px;"><br>2026-03</span>
<span style="font-size:20px;"><br>2026-04</span>
<span style="font-size:20px;"><br>2026-05</span>
<span style="font-size:20px;"><br>**sum**</span>
:::

::: {.column width="10%"}
<br>
<span style="font-size:20px;"><br>7,5 hp</span>
<span style="font-size:20px;"><br>7,5 hp</span>
<span style="font-size:20px;"><br>1,5 hp</span>
<span style="font-size:20px;"><br>1,5 hp</span>
<span style="font-size:20px;"><br>3 hp</span>
<span style="font-size:20px;"><br>1,5 hp</span>
<span style="font-size:20px;"><br>**22,5 hp**</span>
:::

:::: 
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Education</span>

#### Journal clubs and conferences
- <span style="font-size:20px;">**IMA journal club 6 times every term**</span>
    - <span style="font-size:20px;">1,5hp per term, max 6 hp</span>

- <span style="font-size:20px;">**Presentation at international conference**</span>
    - <span style="font-size:20px;">3 planned conferences, among 1 of which planned presentation; 1,5hp</span>
<br>
<img src="images/ki-ds.png" class="logo">
---

#### Degree outcomes
<span style="font-size:30px;">**9A - Knowledge and understanding**</span>

  - <span style="font-size:20px;">Clinical work</span>
  - <span style="font-size:20px;">Microvascular investigations and methodological evaluation</span>
  - <span style="font-size:20px;">Design and completion of studies</span>

<br>
<img src="images/ki-ds.png" class="logo">
---

#### Degree outcomes

<span style="font-size:30px;">**9B - Proficiency and ability**</span>

  - <span style="font-size:20px;">Educational courses</span>
  - <span style="font-size:20px;">Journal clubs</span>
  - <span style="font-size:20px;">Planning and executing studies</span>
  - <span style="font-size:20px;">Writing manuscripts and presenting research</span>

<br>
<img src="images/ki-ds.png" class="logo">
---

#### Degree outcomes
<span style="font-size:30px;">**9C - Judgement and approach**</span>

  - <span style="font-size:20px;">Educational courses in ethics and executing clinical studies</span>
  - <span style="font-size:20px;">Independently solve complex problems while adhering to high standards of scientific practice</span>
<br>
<img src="images/ki-ds.png" class="logo">
---

#### Timeline and Milestones
```{mermaid}
---
displayMode: compact
---
gantt
    axisFormat %Y-%m
    dateFormat YYYY-MM
    section CapriS
        Inclusion(start 2021) :2023-01, 2025-06
        Analysis              :2025-06, 2026-01
        Writing & publication :2026-01, 2026-12
    section MIND
        Inclusion             :2023-06, 2026-01
        Analysis              :2026-01, 2026-10
        Writing & publication :2026-10, 2027-07
    section SCAPIS2spectrum
        Inclusion             :2024-06, 2026-06
        Analysis              :2026-06, 2027-06
        Writing & publication :2027-06, 2028-06
    section Conferences
        [...]Microcirculation                       :milestone    2025-05, 2025-06
        ISICEM                                      :milestone    2026-03, 2026-04
        European Society on Microcirculation        :milestone    2027-04, 2027-05
    section Journal clubs
        IMA-Journal Clubs                           :2024-08, 2029-05
    section Milestones
        Start date                                  :milestone,           2024-08, 2024-08
        Half-Time Control                           :milestone,           2026-08, 2026-08
        Dissertation Defense                        :milestone, crit,     2029-05, 2029-05
```

<br>
<img src="images/ki-ds.png" class="logo">
---

#### Challanges and Risk Management

- <span style="font-size:30px;">**Large Scale Studies**</span>
  - <span style="font-size:20px;">Automatic scheduling system</span>
  - <span style="font-size:20px;">Partially automatic data collection and integrity system</span>

- <span style="font-size:30px;">**Data Analysis Phase**</span>
  - <span style="font-size:25px;">Well-defined analytic aims</span>
  - <span style="font-size:25px;">Specific courses</span>
<br>
<img src="images/ki-ds.png" class="logo">
---

#### Resources and Support

<span style="font-size:30px;">**Supervisor**: Sara Tehrani, MD, PhD, MICU specialist</span>
<div style="margin-top: 80px;"></div>
<span style="font-size:30px;">**Co-Supervisor**: Maria Cronhjort, MD, PhD, anesthesiologist and ICU specialist</span>
<div style="margin-top: 80px;"></div>
<span style="font-size:30px;">**KFC statistician**</span>
<div style="margin-top: 80px;"></div>
<span style="font-size:30px;">**Computer and workplace**</span>
<div style="margin-top: 80px;"></div>
<img src="images/ki-ds.png" class="logo">
---

#### Discussion and Feedback

<br>
<img src="images/ki-ds.png" class="logo">
---